problendoПроблемы ЭндокринологииProblems of Endocrinology0375-96602308-1430Endocrinology Research Centre10.14341/probl201460667-77problendo-7057Research ArticleСтатьиArticlesФедеральные клинические рекомендации по диагностике и лечению токсического зобаThe federal clinical recommendations on diagnostics and treatment of toxic goiterТрошинаЕ АTroshinaEkaterina Atroshina@inbox.ruСвириденкоН ЮSviridenkoNatalya Yueditorial@endocrincentr.ruВанушкоВ ЭVanushkoVladimir Evanushko@gmail.comРумянцевП ОRumyantsevPavel Oeditorial@endocrincentr.ruФадеевВ ВFadeevValentin VWalfad@mail.ruПетунинаН АPetuninaNina Aeditorial@endocrincentr.ruФГБУ «Эндокринологический научный центр» Минздрава России, МоскваРоссияEndocrinology Research Centre, MoscowRussian FederationГБОУ ВПО «Первый московский государственный медицинский университет им. И.М. Сеченова», МоскваРоссияI.M. Sechenov First Moscow State Medical University, MoscowRussian FederationФГБУ «Эндокринологический научный центр» Минздрава России, МоскваРоссияSechenov First Moscow State Medical University, MoscowRussian Federation201415122014606ТОМ 60, №6 (2014)6777Copyright © Трошина Е.А., Свириденко Н.Ю., Ванушко В.Э., Румянцев П.О., Фадеев В.В., Петунина Н.А., 20142014Трошина Е.А., Свириденко Н.Ю., Ванушко В.Э., Румянцев П.О., Фадеев В.В., Петунина Н.А.Troshina E.A., Sviridenko N.Y., Vanushko V.E., Rumyantsev P.O., Fadeev V.V., Petunina N.A.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.probl-endojournals.ru/jour/article/view/7057

Клинические рекомендации обсуждают современные подходы к диагностике и лечению заболеваний, протекающих с тиреотоксикозом.

The proposed clinical recommendations discuss the modern approaches to diagnostics and treatment of the diseases with the clinical picture of thyrotoxicosis.

щитовидная железаболезнь Грейвсамногоузловой токсический зобthyroid glandGraves’ diseasetoxic multinodular goiterReferencesДедов И.И., Мельниченко Г.А., Свириденко Н.Ю. Платонова Н.М., Молашенко Н.В., Егоров А.В. Диагностика, лечение и профилактика ятрогенных йодиндуцированных заболеваний щитовидной железы // Вестник Российской Академии Медицинских Наук. – 2006. – №2. – С. 15-22. [ Dedov II, Melnichenko GA, Sviridenko NY, Platonova NM, Molashenko NV, Yegorov AV. Diagnostics, treatment, and prevention of iatrogenic iodine-induced thyroid gland diseases. Vestn Ross Akad Med Nauk 2006;(2):15-22.]Дедов И.И., Мельниченко Г.А., Свириденко Н.Ю. Платонова Н.М., Молашенко Н.В., Егоров А.В. Диагностика, лечение и профилактика ятрогенных йодиндуцированных заболеваний щитовидной железы // Вестник Российской Академии Медицинских Наук. – 2006. – №2. – С. 15-22. [ Dedov II, Melnichenko GA, Sviridenko NY, Platonova NM, Molashenko NV, Yegorov AV. Diagnostics, treatment, and prevention of iatrogenic iodine-induced thyroid gland diseases. Vestn Ross Akad Med Nauk 2006;(2):15-22.]Дедов И.И., Мельниченко Г.А., Фадеев В.В. Эндокринология. М.: «ГЭОТАР –Медиа»; 2009. - 422 с. [ Dedov II, Mel'nichenko GA, Fadeyev VV. Endocrinology. Moscow: «GEOTAR–Media»; 2009.]Дедов И.И., Мельниченко Г.А., Фадеев В.В. Эндокринология. М.: «ГЭОТАР –Медиа»; 2009. - 422 с. [ Dedov II, Mel'nichenko GA, Fadeyev VV. Endocrinology. Moscow: «GEOTAR–Media»; 2009.]Дедов И.И., Мельниченко Г.А., Фадеев В.В. Эндокринология. М.: Медицина; 2000. - С. 172-179. [ Dedov I.I., Mel'nichenko G.A., Fadeyev V.V. Endocrinology. Moscow: Meditsina; 2000.]Дедов И.И., Мельниченко Г.А., Фадеев В.В. Эндокринология. М.: Медицина; 2000. - С. 172-179. [ Dedov I.I., Mel'nichenko G.A., Fadeyev V.V. Endocrinology. Moscow: Meditsina; 2000.]Диагностика и лечение заболевания щитовидной железы во время беременности и в послеродовом периоде: по материалам клинических рекомендаций эндокринологической ассоциации США. / Перевод и комментарии В. В. Фадеева. 2007. Режим доступа: http://www.thyronet.rusmedserv.com/ [Diagnosis and treatment of thyroid disease during pregnancy and the postpartum period: based on American Association of Clinical Endocrinologists. Translation and Commentary by Fadeyev V.V. 2007.]Диагностика и лечение заболевания щитовидной железы во время беременности и в послеродовом периоде: по материалам клинических рекомендаций эндокринологической ассоциации США. / Перевод и комментарии В. В. Фадеева. 2007. Режим доступа: http://www.thyronet.rusmedserv.com/ [Diagnosis and treatment of thyroid disease during pregnancy and the postpartum period: based on American Association of Clinical Endocrinologists. Translation and Commentary by Fadeyev V.V. 2007.]Menconi F, Marccci C, Marino M. Diagnosis and classification of Graves’ disease. Autoimmun Revews. 2014;13(4W5):398W402. doi: 10.1016/j.autrev.2014.01.013Menconi F, Marccci C, Marino M. Diagnosis and classification of Graves’ disease. Autoimmun Revews. 2014;13(4W5):398W402. doi: 10.1016/j.autrev.2014.01.013Мельниченко Г.А. Болезни щитовидной железы и беременность: В кн.: Болезни органов эндокринной системы (руководство по внутренним болезням) / Под ред. И.И. Дедова. — М.: Медицина, 2002. [Mel'nichenko G.A. Thyroid Disease and Pregnancy. In book: Diseases of the endocrine system (manual of internal medicine). Ed by I.I. Dedov. Moscow: Meditsina; 2002.]Мельниченко Г.А. Болезни щитовидной железы и беременность: В кн.: Болезни органов эндокринной системы (руководство по внутренним болезням) / Под ред. И.И. Дедова. — М.: Медицина, 2002. [Mel'nichenko G.A. Thyroid Disease and Pregnancy. In book: Diseases of the endocrine system (manual of internal medicine). Ed by I.I. Dedov. Moscow: Meditsina; 2002.]Свириденко Н.Ю., Платонова Н.М., Молашенко Н.В., Голицин С.П., Бакалов С.А., Сердюк С.Е. Эндокринные аспекты применения амиодарона в клинической практике. (Алгоритм наблюдения и лечения функциональных расстройств щитовидной железы) // Российский кардиологический журнал. – 2012. – №2. – С. 63–71. [ Sviridenko NY, Platonova NM, Molashenko NV, Golitsyn SP, Bakalov SA, Serdyuk SE. Endocrine aspects of amiodarone therapy in clinical practice (Follow-up and treatment algorithm for patients with thyroid dysfunction). Rossiĭskiĭ kardiologicheskiĭ zhurnal 2012;(2):63-71.]Свириденко Н.Ю., Платонова Н.М., Молашенко Н.В., Голицин С.П., Бакалов С.А., Сердюк С.Е. Эндокринные аспекты применения амиодарона в клинической практике. (Алгоритм наблюдения и лечения функциональных расстройств щитовидной железы) // Российский кардиологический журнал. – 2012. – №2. – С. 63–71. [ Sviridenko NY, Platonova NM, Molashenko NV, Golitsyn SP, Bakalov SA, Serdyuk SE. Endocrine aspects of amiodarone therapy in clinical practice (Follow-up and treatment algorithm for patients with thyroid dysfunction). Rossiĭskiĭ kardiologicheskiĭ zhurnal 2012;(2):63-71.]Свириденко Н.Ю. Функциональная автономия щитовидной железы // Врач. – 2002. – №6. - C.8-11. [Sviridenko NY. Funktsional'naya avtonomiya shchitovidnoy zhelezy. Vrach 2002;(6):8-11.]Свириденко Н.Ю. Функциональная автономия щитовидной железы // Врач. – 2002. – №6. - C.8-11. [Sviridenko NY. Funktsional'naya avtonomiya shchitovidnoy zhelezy. Vrach 2002;(6):8-11.]Свириденко Н.Ю., Беловалова И.М., Шеремета М.С., Табеева К.И., Ремизов О.В. Болезнь Грейвса и эндокринная офтальмопатия. / Под ред. акад. РАН и РАМН И.И. Дедова и акад. РАМН Г.А. Мельниченко. М.: МАИ-принт; 2012. [Sviridenko NY, Belovalova IM, Sheremeta MS, Tabeeva KI, Remizov OV. Graves' disease and endocrine ophthalmopathy. Ed by I.I. Dedov and G.A. Mel'nichenko. Moscow: MAI-print; 2012.]Свириденко Н.Ю., Беловалова И.М., Шеремета М.С., Табеева К.И., Ремизов О.В. Болезнь Грейвса и эндокринная офтальмопатия. / Под ред. акад. РАН и РАМН И.И. Дедова и акад. РАМН Г.А. Мельниченко. М.: МАИ-принт; 2012. [Sviridenko NY, Belovalova IM, Sheremeta MS, Tabeeva KI, Remizov OV. Graves' disease and endocrine ophthalmopathy. Ed by I.I. Dedov and G.A. Mel'nichenko. Moscow: MAI-print; 2012.]Свириденко Н.Ю., Лихванцева В.Г., Беловалова И.М., Шеремета М.С., Табеева К.И. Антитела к рецептору ТТГ как предикторы тяжести и исходов эндокринной офтальмопатии у пациентов с болезнью Грейвса. // Проблемы эндокринологии. – 2011. – Т. 57. – №2. – C. 23-26. [ Sviridenko NI, Likhvantseva VG, Belovalova IM, Sheremeta MS, Tabeeva KI. Anti-TSH receptor antibodies as predictors of the severity and outcome of endocrine ophthalmopathy in the patients presenting with Graves' disease. Problemy endocrinologii 2011;57(2):23-26.] doi: 10.14341/probl201157223-26Свириденко Н.Ю., Лихванцева В.Г., Беловалова И.М., Шеремета М.С., Табеева К.И. Антитела к рецептору ТТГ как предикторы тяжести и исходов эндокринной офтальмопатии у пациентов с болезнью Грейвса. // Проблемы эндокринологии. – 2011. – Т. 57. – №2. – C. 23-26. [ Sviridenko NI, Likhvantseva VG, Belovalova IM, Sheremeta MS, Tabeeva KI. Anti-TSH receptor antibodies as predictors of the severity and outcome of endocrine ophthalmopathy in the patients presenting with Graves' disease. Problemy endocrinologii 2011;57(2):23-26.] doi: 10.14341/probl201157223-26Фадеев В.В., Абрамова Н.А., Прокофьев С.А., Гитель Е.П., Мельниченко Г.А., Дедов И.И. Антитела к рецептору ТТГ в дифференциальной диагностике токсического зоба // Проблемы эндокринологии. - 2005. - Т. 51. – №4. - С. 10-18. [Fadeyev VV, Abramova NA, Prokof'ev SA, Gitel' EP, Mel'nichenko GA, Dedov II. TSH receptor antibodies in the differential diagnosis of toxic goiter // Problemy endokrinologii 2005;51(4):10-18.]Фадеев В.В., Абрамова Н.А., Прокофьев С.А., Гитель Е.П., Мельниченко Г.А., Дедов И.И. Антитела к рецептору ТТГ в дифференциальной диагностике токсического зоба // Проблемы эндокринологии. - 2005. - Т. 51. – №4. - С. 10-18. [Fadeyev VV, Abramova NA, Prokof'ev SA, Gitel' EP, Mel'nichenko GA, Dedov II. TSH receptor antibodies in the differential diagnosis of toxic goiter // Problemy endokrinologii 2005;51(4):10-18.]Фадеев В.В., Дроздовский Б.Я., Гусева Т.Н., Гарбузов П.И., Бузиашвили И.И., Мельниченко Г.А. Отдалённые результаты лечения токсического зоба радиоактивным 131I // Проблемы эндокринологии. - 2005. - Т. 51. – №1. - С. 3-9. [Fadeyev VV, Drozdovskiy BY, Guseva TN, Garbuzov PI, Buziashvili II, Mel'nichenko GA. Long-term results of treatment of toxic goiter with radioactive 131I. Problemy endokrinologii 2005;51(1):3-9.]Фадеев В.В., Дроздовский Б.Я., Гусева Т.Н., Гарбузов П.И., Бузиашвили И.И., Мельниченко Г.А. Отдалённые результаты лечения токсического зоба радиоактивным 131I // Проблемы эндокринологии. - 2005. - Т. 51. – №1. - С. 3-9. [Fadeyev VV, Drozdovskiy BY, Guseva TN, Garbuzov PI, Buziashvili II, Mel'nichenko GA. Long-term results of treatment of toxic goiter with radioactive 131I. Problemy endokrinologii 2005;51(1):3-9.]Bahn RS, Burch HB, Cooper DS, Garber JR, Greenlee MC, Klein I, et al. Hyperthyroidism and Other Causes of Thyrotoxicosis: Management Guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists. Thyroid. 2011;21(6):593-646. doi: 10.1089/thy.2010.0417Bahn RS, Burch HB, Cooper DS, Garber JR, Greenlee MC, Klein I, et al. Hyperthyroidism and Other Causes of Thyrotoxicosis: Management Guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists. Thyroid. 2011;21(6):593-646. doi: 10.1089/thy.2010.0417Bartalena L, Tanda ML, Piantanida E, Lai A. Glucocorticoids and outcome of radioactive iodine therapy for Graves' hyperthyroidism. European Journal of Endocrinology. 2005;153(1):13-14. doi: 10.1530/eje.1.01938Bartalena L, Tanda ML, Piantanida E, Lai A. Glucocorticoids and outcome of radioactive iodine therapy for Graves' hyperthyroidism. European Journal of Endocrinology. 2005;153(1):13-14. doi: 10.1530/eje.1.01938Cawood TJ, Moriarty P, O’Farrelly C, O’Shea D. Smoking and Thyroid-Associated Ophthalmopathy: A Novel Explanation of the Biological Link. The Journal of Clinical Endocrinology & Metabolism. 2007;92(1):59-64. doi: 10.1210/jc.2006-1824Cawood TJ, Moriarty P, O’Farrelly C, O’Shea D. Smoking and Thyroid-Associated Ophthalmopathy: A Novel Explanation of the Biological Link. The Journal of Clinical Endocrinology & Metabolism. 2007;92(1):59-64. doi: 10.1210/jc.2006-1824De Groot L, Abalovich M, Alexander EK, Amino N, Barbour L, Cobin RH, et al. Management of Thyroid Dysfunction during Pregnancy and Postpartum: An Endocrine Society Clinical Practice Guideline. The Journal of Clinical Endocrinology & Metabolism. 2012;97(8):2543-2565. doi: 10.1210/jc.2011-2803De Groot L, Abalovich M, Alexander EK, Amino N, Barbour L, Cobin RH, et al. Management of Thyroid Dysfunction during Pregnancy and Postpartum: An Endocrine Society Clinical Practice Guideline. The Journal of Clinical Endocrinology & Metabolism. 2012;97(8):2543-2565. doi: 10.1210/jc.2011-2803Esfahani AF, Kakhki VR, Fallahi B, Eftekhari M, Beiki D, Saghari M, et al. Comparative evaluation of two fixed doses of 185 and 370 MBq 131I, for the treatment of Graves' disease resistant to antithyroid drugs. Hellenic Journal of Nuclear Medicine. 2005;8(3):158-161.Esfahani AF, Kakhki VR, Fallahi B, Eftekhari M, Beiki D, Saghari M, et al. Comparative evaluation of two fixed doses of 185 and 370 MBq 131I, for the treatment of Graves' disease resistant to antithyroid drugs. Hellenic Journal of Nuclear Medicine. 2005;8(3):158-161.Fadeyev V. Clinical Aspects of Thyroid Disorders in the Elderly. Thyroid Int. 2007 (3):3-15.Fadeyev V. Clinical Aspects of Thyroid Disorders in the Elderly. Thyroid Int. 2007 (3):3-15.Ginsberg J. Diagnosis and management of Graves' disease. Canadian Medical Association Journal. 2003 March 4, 2003;168(5):575-585.Ginsberg J. Diagnosis and management of Graves' disease. Canadian Medical Association Journal. 2003 March 4, 2003;168(5):575-585.Järhult J, Rudberg C, Larsson E, Selvander H, Sjövall K, Winsa B, et al. Graves' Disease with Moderate–Severe Endocrine Ophthalmopathy–Long Term Results of a Prospective, Randomized Study of Total or Subtotal Thyroid Resection. Thyroid. 2005;15(10):1157-1164. doi: 10.1089/thy.2005.15.1157Järhult J, Rudberg C, Larsson E, Selvander H, Sjövall K, Winsa B, et al. Graves' Disease with Moderate–Severe Endocrine Ophthalmopathy–Long Term Results of a Prospective, Randomized Study of Total or Subtotal Thyroid Resection. Thyroid. 2005;15(10):1157-1164. doi: 10.1089/thy.2005.15.1157Lal G, Ituarte P, Kebebew E, Siperstein A, Duh Q-Y, Clark OH. Should Total Thyroidectomy Become the Preferred Procedure for Surgical Management of Graves' Disease? Thyroid. 2005;15(6):569-574. doi: 10.1089/thy.2005.15.569Lal G, Ituarte P, Kebebew E, Siperstein A, Duh Q-Y, Clark OH. Should Total Thyroidectomy Become the Preferred Procedure for Surgical Management of Graves' Disease? Thyroid. 2005;15(6):569-574. doi: 10.1089/thy.2005.15.569Lepner U, Seire I, Palmiste V, Kirsimägi Ü. Surgical treatment of Graves’ disease: subtotal thyroidectomy might still be the preferred option. Medicina (Kaunas, Lithuania). 2008;44(1):22-26.Lepner U, Seire I, Palmiste V, Kirsimägi Ü. Surgical treatment of Graves’ disease: subtotal thyroidectomy might still be the preferred option. Medicina (Kaunas, Lithuania). 2008;44(1):22-26.Mandel SJ, Cooper DS. The Use of Antithyroid Drugs in Pregnancy and Lactation. The Journal of Clinical Endocrinology & Metabolism. 2001 2001/06/01;86(6):2354-2359. doi: 10.1210/jcem.86.6.7573Mandel SJ, Cooper DS. The Use of Antithyroid Drugs in Pregnancy and Lactation. The Journal of Clinical Endocrinology & Metabolism. 2001 2001/06/01;86(6):2354-2359. doi: 10.1210/jcem.86.6.7573Manji N, Carr-Smith JD, Boelaert K, Allahabadia A, Armitage M, Chatterjee VK, et al. Influences of Age, Gender, Smoking, and Family History on Autoimmune Thyroid Disease Phenotype. The Journal of Clinical Endocrinology & Metabolism. 2006;91(12):4873-4880. doi: 10.1210/jc.2006-1402Manji N, Carr-Smith JD, Boelaert K, Allahabadia A, Armitage M, Chatterjee VK, et al. Influences of Age, Gender, Smoking, and Family History on Autoimmune Thyroid Disease Phenotype. The Journal of Clinical Endocrinology & Metabolism. 2006;91(12):4873-4880. doi: 10.1210/jc.2006-1402Menconi F, Marinò M, Pinchera A, Rocchi R, Mazzi B, Nardi M, et al. Effects of Total Thyroid AblationVersusNear-Total Thyroidectomy Alone on Mild to Moderate Graves’ Orbitopathy Treated with Intravenous Glucocorticoids. The Journal of Clinical Endocrinology & Metabolism. 2007;92(5):1653-1658. doi: 10.1210/jc.2006-1800Menconi F, Marinò M, Pinchera A, Rocchi R, Mazzi B, Nardi M, et al. Effects of Total Thyroid AblationVersusNear-Total Thyroidectomy Alone on Mild to Moderate Graves’ Orbitopathy Treated with Intravenous Glucocorticoids. The Journal of Clinical Endocrinology & Metabolism. 2007;92(5):1653-1658. doi: 10.1210/jc.2006-1800The European Group of Graves’ Orbitopathy; Perros P, Baldeschi L, Boboridis K, Dickinson AJ, Hullo A, et al. A questionnaire survey on the management of Graves' orbitopathy in Europe. European Journal of Endocrinology. 2006;155(2):207-211. doi: 10.1530/eje.1.02201The European Group of Graves’ Orbitopathy; Perros P, Baldeschi L, Boboridis K, Dickinson AJ, Hullo A, et al. A questionnaire survey on the management of Graves' orbitopathy in Europe. European Journal of Endocrinology. 2006;155(2):207-211. doi: 10.1530/eje.1.02201Prummel M, Bakker A, Wiersinga W, Baldeschi L, Mourits M, Kendall-Taylor P, et al. Multi-center study on the characteristics and treatment strategies of patients with Graves' orbitopathy: the first European Group on Graves' Orbitopathy experience. European Journal of Endocrinology. 2003;148(5):491-495. doi: 10.1530/eje.0.1480491Prummel M, Bakker A, Wiersinga W, Baldeschi L, Mourits M, Kendall-Taylor P, et al. Multi-center study on the characteristics and treatment strategies of patients with Graves' orbitopathy: the first European Group on Graves' Orbitopathy experience. European Journal of Endocrinology. 2003;148(5):491-495. doi: 10.1530/eje.0.1480491Sridama V, DeGroot LJ. Treatment of Graves' disease and the course of ophthalmopathy. The American Journal of Medicine. 1989;87(1):70-73. doi: 10.1016/s0002-9343(89)80485-1Sridama V, DeGroot LJ. Treatment of Graves' disease and the course of ophthalmopathy. The American Journal of Medicine. 1989;87(1):70-73. doi: 10.1016/s0002-9343(89)80485-1Stagnaro-Green A, Abalovich M, Alexander E, Azizi F, Mestman J, Negro R, et al. Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and Postpartum. Thyroid. 2011;21(10):1081-1125. doi: 10.1089/thy.2011.0087Stagnaro-Green A, Abalovich M, Alexander E, Azizi F, Mestman J, Negro R, et al. Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and Postpartum. Thyroid. 2011;21(10):1081-1125. doi: 10.1089/thy.2011.0087Thornton J, Kelly SP, Harrison RA, Edwards R. Cigarette smoking and thyroid eye disease: a systematic review. Eye. 2006;21(9):1135-1145. doi: 10.1038/sj.eye.6702603Thornton J, Kelly SP, Harrison RA, Edwards R. Cigarette smoking and thyroid eye disease: a systematic review. Eye. 2006;21(9):1135-1145. doi: 10.1038/sj.eye.6702603Toft AD. Subclinical Hyperthyroidism. New England Journal of Medicine. 2001;345(7):512-516. doi: 10.1056/NEJMcp010145Toft AD. Subclinical Hyperthyroidism. New England Journal of Medicine. 2001;345(7):512-516. doi: 10.1056/NEJMcp010145Wallaschofski H, Orda C, Georgi P, Miehle K, Paschke R. Distinction Between Autoimmune and Non-Autoimmune Hyperthyroidism by Determination of TSH-Receptor Antibodies in Patients with the Initial Diagnosis of Toxic Multinodular Goiter. Hormone and Metabolic Research. 2001;33(8):504-507. doi: 10.1055/s-2001-16945Wallaschofski H, Orda C, Georgi P, Miehle K, Paschke R. Distinction Between Autoimmune and Non-Autoimmune Hyperthyroidism by Determination of TSH-Receptor Antibodies in Patients with the Initial Diagnosis of Toxic Multinodular Goiter. Hormone and Metabolic Research. 2001;33(8):504-507. doi: 10.1055/s-2001-16945Weetman AP. Graves' Disease. New England Journal of Medicine. 2000;343(17):1236-1248. doi: 10.1056/nejm200010263431707Weetman AP. Graves' Disease. New England Journal of Medicine. 2000;343(17):1236-1248. doi: 10.1056/nejm200010263431707Werga-Kjellman P, Zedenius J, Tallstedt L, Träisk F, Lundell G, Wallin G. Surgical Treatment of Hyperthyroidism: A Ten-Year Experience. Thyroid. 2001;11(2):187-192. doi: 10.1089/105072501300042947Werga-Kjellman P, Zedenius J, Tallstedt L, Träisk F, Lundell G, Wallin G. Surgical Treatment of Hyperthyroidism: A Ten-Year Experience. Thyroid. 2001;11(2):187-192. doi: 10.1089/105072501300042947Wiersinga WM, Bartalena L. Epidemiology and Prevention of Graves' Ophthalmopathy. Thyroid. 2002;12(10):855-860. doi: 10.1089/105072502761016476Wiersinga WM, Bartalena L. Epidemiology and Prevention of Graves' Ophthalmopathy. Thyroid. 2002;12(10):855-860. doi: 10.1089/105072502761016476Wiersinga WM, Perros P, Kahaly GJ, Mourits MP, Baldeschi L, Boboridis K, et al. Clinical assessment of patients with Graves' orbitopathy: the European Group on Graves' Orbitopathy recommendations to generalists, specialists and clinical researchers. European Journal of Endocrinology. 2006;155(3):387-389. doi: 10.1530/eje.1.02230Wiersinga WM, Perros P, Kahaly GJ, Mourits MP, Baldeschi L, Boboridis K, et al. Clinical assessment of patients with Graves' orbitopathy: the European Group on Graves' Orbitopathy recommendations to generalists, specialists and clinical researchers. European Journal of Endocrinology. 2006;155(3):387-389. doi: 10.1530/eje.1.02230

The authors declare that there are no conflicts of interest present.